vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and OP Bancorp (OPBK). Click either name above to swap in a different company.
OP Bancorp is the larger business by last-quarter revenue ($24.3M vs $13.8M, roughly 1.8× FENNEC PHARMACEUTICALS INC.). On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 13.7%). Over the past eight quarters, OP Bancorp's revenue compounded faster (11.4% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.
FENC vs OPBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $24.3M |
| Net Profit | $-4.8M | — |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 39.2% |
| Net Margin | -34.7% | — |
| Revenue YoY | 73.8% | 13.7% |
| Net Profit YoY | -141.1% | — |
| EPS (diluted) | $-0.17 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $24.3M | ||
| Q3 25 | $12.5M | $24.5M | ||
| Q2 25 | $9.7M | $23.7M | ||
| Q1 25 | $8.8M | $22.2M | ||
| Q4 24 | $7.9M | $21.3M | ||
| Q3 24 | $7.0M | $20.7M | ||
| Q2 24 | $7.3M | $20.4M | ||
| Q1 24 | $25.4M | $19.6M |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-638.0K | $6.7M | ||
| Q2 25 | $-3.2M | $6.3M | ||
| Q1 25 | $-1.2M | $5.6M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-5.7M | $5.4M | ||
| Q2 24 | $-5.6M | $5.4M | ||
| Q1 24 | $12.8M | $5.2M |
| Q4 25 | -18.5% | 39.2% | ||
| Q3 25 | -1.5% | 39.5% | ||
| Q2 25 | -28.3% | 35.7% | ||
| Q1 25 | -9.2% | 34.6% | ||
| Q4 24 | -11.8% | 31.2% | ||
| Q3 24 | -74.6% | 36.5% | ||
| Q2 24 | -69.4% | 37.2% | ||
| Q1 24 | 54.2% | 37.1% |
| Q4 25 | -34.7% | — | ||
| Q3 25 | -5.1% | 27.4% | ||
| Q2 25 | -32.7% | 26.7% | ||
| Q1 25 | -13.3% | 25.0% | ||
| Q4 24 | -25.0% | — | ||
| Q3 24 | -82.2% | 26.2% | ||
| Q2 24 | -76.5% | 26.7% | ||
| Q1 24 | 50.6% | 26.7% |
| Q4 25 | $-0.17 | $0.48 | ||
| Q3 25 | $-0.02 | $0.45 | ||
| Q2 25 | $-0.11 | $0.42 | ||
| Q1 25 | $-0.04 | $0.37 | ||
| Q4 24 | $-0.02 | $0.33 | ||
| Q3 24 | $-0.21 | $0.36 | ||
| Q2 24 | $-0.20 | $0.36 | ||
| Q1 24 | $0.41 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $227.9M |
| Total Assets | $70.6M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $167.3M | ||
| Q3 25 | $21.9M | $166.7M | ||
| Q2 25 | $18.7M | $205.4M | ||
| Q1 25 | $22.7M | $198.9M | ||
| Q4 24 | $26.6M | $134.9M | ||
| Q3 24 | $40.3M | $166.8M | ||
| Q2 24 | $43.1M | $127.7M | ||
| Q1 24 | $51.2M | $139.2M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $227.9M | ||
| Q3 25 | $-4.5M | $221.5M | ||
| Q2 25 | $-7.5M | $213.7M | ||
| Q1 25 | $-5.9M | $210.1M | ||
| Q4 24 | $-5.9M | $205.0M | ||
| Q3 24 | $-5.2M | $203.6M | ||
| Q2 24 | $-1.4M | $195.9M | ||
| Q1 24 | $3.0M | $194.7M |
| Q4 25 | $70.6M | $2.7B | ||
| Q3 25 | $49.3M | $2.6B | ||
| Q2 25 | $44.9M | $2.6B | ||
| Q1 25 | $46.4M | $2.5B | ||
| Q4 24 | $44.9M | $2.4B | ||
| Q3 24 | $58.9M | $2.4B | ||
| Q2 24 | $63.2M | $2.3B | ||
| Q1 24 | $69.2M | $2.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $26.2M |
| Free Cash FlowOCF − Capex | — | $23.4M |
| FCF MarginFCF / Revenue | — | 96.2% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $26.2M | ||
| Q3 25 | $1.5M | $23.9M | ||
| Q2 25 | $-3.7M | $-7.0M | ||
| Q1 25 | $-4.3M | $5.6M | ||
| Q4 24 | $-1.5M | $31.2M | ||
| Q3 24 | $-2.2M | $13.3M | ||
| Q2 24 | $-8.4M | $15.8M | ||
| Q1 24 | $39.0M | $-3.2M |
| Q4 25 | — | $23.4M | ||
| Q3 25 | — | $23.4M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $15.7M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | 96.2% | ||
| Q3 25 | — | 95.6% | ||
| Q2 25 | — | -32.5% | ||
| Q1 25 | — | 19.0% | ||
| Q4 24 | — | 139.0% | ||
| Q3 24 | — | 61.5% | ||
| Q2 24 | — | 77.0% | ||
| Q1 24 | — | -16.6% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.57× | ||
| Q2 25 | — | -1.10× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.45× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | 3.04× | -0.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
